Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1401-1410 Newer>

The Motley Fool September 10, 2004 Zeke Ashton	When Good Companies Get Bad Breaks Emotion is a part of the investing game and can be hard to master when a favorite company falls on hard times, like Utah Medical Products.
The Motley Fool September 10, 2004 Charly Travers	Looming Drug Shortages The push for drug re-importation into the U.S. will have consequences abroad. With supply restrictions in place, Canada and the U.K. are at a higher risk of drug shortages if pharmacies in those countries continue to sell drugs to U.S. citizens.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
InternetNews September 7, 2004 Clint Boulton	IBM's Blue Gene Breaks New Research Ground The four-rack supercomputer system will map protein structures in the hope of manufacturing more effective drugs for humans.
The Motley Fool September 3, 2004 Charly Travers	MGI Pharma's Shopping Spree The company is filling out its drug pipeline with acquisitions.
The Motley Fool September 2, 2004 Rich Smith	Translating Your Doctor Bill A lawsuit is currently in the works aiming to overturn an unfunded federal mandate that requires federally funded hospitals, clinics, and doctors to make translators available to patients who speak limited English.
The Motley Fool September 1, 2004 W.D. Crotty	A Pall Falls Over Forest One of Forest Labs' Alzheimer's drugs fails in phase 3 trials. For investors willing to take the political risk, today's drug news has taken a battered stock, with a great balance sheet, to very reasonable price levels.
The Motley Fool September 1, 2004 Bill Mann	Triumph of Hope Over Reason A frighteningly expensive drug of marginal efficacy begets triple-digit multiples? Bring on the miracles. Standard & Poor's reiterated its "buy" rating of ImClone.
Managed Care August 2004 Marilyn Bydalek	Navigating the Personnel Rapids: What They Never Taught You in Med School Physicians who make the move to the administrative side find a lot of tough decisions waiting for them.
Managed Care August 2004 Alan Lotvin	Specialty Pharmacy Presents Unique Set of Challenges Only a small percent of a typical health plan's population takes medicine for conditions outside the generalist's scope. But it's a big portion of the drug bill.
<Older 1401-1410 Newer> Return to current articles.